Charles Schwab’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-921,422
| Closed | -$78.3M | – | 3437 |
|
|
2020
Q3 | $78.3M | Sell |
921,422
-104,329
| -10% | -$5.28M | 0.04% | 432 |
|
|
2020
Q2 | $36.4M | Sell |
1,025,751
-207,863
| -17% | -$6.08M | 0.02% | 771 |
|
|
2020
Q1 | $16.6M | Buy |
1,233,614
+58,623
| +5% | +$986K | 0.01% | 1137 |
|
|
2019
Q4 | $24.9M | Buy |
1,174,991
+75,991
| +7% | +$1.34M | 0.01% | 1066 |
|
|
2019
Q3 | $14.6M | Buy |
1,099,000
+27,631
| +3% | +$406K | 0.01% | 1354 |
|
|
2019
Q2 | $14.9M | Buy |
1,071,369
+80,142
| +8% | +$1.21M | 0.01% | 1351 |
|
|
2019
Q1 | $19M | Buy |
991,227
+98,605
| +11% | +$1.59M | 0.01% | 1146 |
|
|
2018
Q4 | $12.7M | Buy |
892,622
+39,997
| +5% | +$794K | 0.01% | 1286 |
|
|
2018
Q3 | $17.8M | Buy |
852,625
+67,526
| +9% | +$1.6M | 0.01% | 1223 |
|
|
2018
Q2 | $18.6M | Buy |
785,099
+236,774
| +43% | +$4.76M | 0.01% | 1146 |
|
|
2018
Q1 | $8.01M | Buy |
548,325
+31,066
| +6% | +$508K | 0.01% | 1655 |
|
|
2017
Q4 | $8.36M | Buy |
517,259
+48,879
| +10% | +$577K | 0.01% | 1610 |
|
|
2017
Q3 | $6.55M | Buy |
468,380
+281,032
| +150% | +$2.8M | 0.01% | 1736 |
|
|
2017
Q2 | $1.66M | Buy |
187,348
+26,400
| +16% | +$185K | ﹤0.01% | 2287 |
|
|
2017
Q1 | $1.04M | Sell |
160,948
-75,600
| -32% | -$383K | ﹤0.01% | 2410 |
|
|
2016
Q4 | $869K | Buy |
236,548
+39,500
| +20% | +$117K | ﹤0.01% | 2478 |
|
|
2016
Q3 | $641K | Hold |
197,048
| – | – | ﹤0.01% | 2535 |
|
|
2016
Q2 | $458K | Hold |
197,048
| – | – | ﹤0.01% | 2619 |
|
|
2016
Q1 | $493K | Hold |
197,048
| – | – | ﹤0.01% | 2584 |
|
|
2015
Q4 | $605K | Sell |
197,048
-42,400
| -18% | -$118K | ﹤0.01% | 2562 |
|
|
2015
Q3 | $412K | Buy |
239,448
+42,700
| +22% | +$109K | ﹤0.01% | 2695 |
|
|
2015
Q2 | $799K | Hold |
196,748
| – | – | ﹤0.01% | 2510 |
|
|
2015
Q1 | $754K | Hold |
196,748
| – | – | ﹤0.01% | 2479 |
|
|
2014
Q4 | $945K | Hold |
196,748
| – | – | ﹤0.01% | 2372 |
|
|
2014
Q3 | $732K | Hold |
196,748
| – | – | ﹤0.01% | 2445 |
|
|
2014
Q2 | $719K | Buy |
196,748
+67,448
| +52% | +$248K | ﹤0.01% | 2485 |
|
|
2014
Q1 | $545K | Hold |
129,300
| – | – | ﹤0.01% | 2559 |
|
|
2013
Q4 | $595K | Hold |
129,300
| – | – | ﹤0.01% | 2526 |
|
|
2013
Q3 | $881K | Sell |
129,300
-103,000
| -44% | -$593K | ﹤0.01% | 2272 |
|
|
2013
Q2 | $1.28M | Buy |
+232,300
| New | +$763K | ﹤0.01% | 2020 |
|
Charles Schwab's IMMU Position: Q4 2020 in Review
Charles Schwab sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 921,422 shares — an estimated $78.3M sold.
Charles Schwab first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $78.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Charles Schwab reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Charles Schwab sold 921,422 Immunomedics Inc shares in Q4 2020, an estimated $78.3M.
- Charles Schwab first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Charles Schwab's Immunomedics Inc position peaked at $78.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.